Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo-Reference-Cited by-同舟云学术

Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo

Published:2008-07-07 Issue:2 Volume:181 Page:1120-1127
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Forssmann Ulf,Stoetzer Carsten,Stephan Michael,Kruschinski Carsten,Skripuletz Thomas,Schade Jutta,Schmiedl Andreas,Pabst Reinhard,Wagner Leona,Hoffmann Torsten,Kehlen Astrid,Escher Sylvia E.,Forssmann Wolf-Georg,Elsner Jörn,von Hörsten Stephan

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Chemokines and disease

2. Chemokines — Chemotactic Cytokines That Mediate Inflammation

3. CD26: A Multifunctional Integral Membrane and Secreted Protein of Activated Lymphocytes

4. Improved Glucose Tolerance in Zucker Fatty Rats by Oral Administration of the Dipeptidyl Peptidase IV Inhibitor Isoleucine Thiazolidide

5. Finding New Treatments for Diabetes — How Many, How Fast . . . How Good?

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Dipeptidiyl Peptidase-4 Inhibitors and Bullose Pemphigoid: A Report of Four Cases;Medeniyet Medical Journal;2024-06-28

2. Gliptin-induced bullous pemphigoid;Int. Journal of Clinical Pharmacology and Therapeutics;2024-02-01

3. Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report;American Journal of Ophthalmology Case Reports;2023-12

4. From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid;International Journal of Molecular Sciences;2023-11-26

5. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid diagnosed by oral manifestation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-11